(Q44344640)

2 December 2017

title

Ibogaine and noribogaine potentiate the inhibition of adenylyl cyclase activity by opioid and 5-HT receptors (English)

1 reference

2 December 2017

0 references

1 reference

Rabin RA

1

1 reference

2 December 2017

Winter JC

series ordinal

2

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 December 1996

1 reference

European Journal of Pharmacology

2 December 2017

published in

1 reference

2 December 2017

volume

316

1 reference

2 December 2017

issue

2-3

1 reference

2 December 2017

page(s)

343-348

1 reference

Ibogaine and its congeners are sigma 2 receptor-selective ligands with moderate affinity

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900690-5

Inhibitory effects of ibogaine on cocaine self-administration in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900690-5

The inhibitory effect of norharman on morphine withdrawal syndrome in rats: comparison with ibogaine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900690-5

Opioid receptor-coupled second messenger systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900690-5

High affinity ibogaine binding to a mu opioid agonist site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900690-5

Mechanisms of action of ibogaine and harmaline congeners based on radioligand binding studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900690-5

Identification and quantification of the indole alkaloid ibogaine in biological samples by gas chromatography-mass spectrometry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900690-5

Endogenous opioids are involved in the genetically determined high preference for ethanol consumption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900690-5

18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900690-5

Effects of iboga alkaloids on morphine and cocaine self-administration in rats: relationship to tremorigenic effects and to effects on dopamine release in nucleus accumbens and striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900690-5

Effects and aftereffects of ibogaine on morphine self-administration in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900690-5

Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900690-5

Ibogaine possesses a selective affinity for σ2 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900690-5

Acute and prolonged effects of ibogaine on brain dopamine metabolism and morphine-induced locomotor activity in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900690-5

Identification of a primary metabolite of ibogaine that targets serotonin transporters and elevates serotonin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900690-5

Properties of ibogaine and its principal metabolite (12-hydroxyibogamine) at the MK-801 binding site of the NMDA receptor complex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900690-5

Radioligand-binding study of noribogaine, a likely metabolite of ibogaine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900690-5

The putative anti-addictive drug ibogaine is a competitive inhibitor of [3H]MK-801 binding to the NMDA receptor complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900690-5

Attenuation of alcohol intake by ibogaine in three strains of alcohol-preferring rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900690-5

Potentiation action of ibogaine (bogadin TM) on morphine analgesia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900690-5

Ibogaine reduces preference for cocaine consumption in C57BL/6By mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900690-5

A preliminary investigation of ibogaine: case reports and recommendations for further study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900690-5

Receptor binding profile suggests multiple mechanisms of action are responsible for ibogaine's putative anti-addictive activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900690-5

Alcohol drinking in rats during and following morphine injections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900690-5

Cyclic AMP mediates mu and delta, but not kappa opioid analgesia in the spinal cord of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900690-5

10.1016/S0014-2999(96)00690-5

7 January 2021

Identifiers

DOI

1 reference

2 December 2017

1 reference